Back to RU Rubric Capital Management LP

STMLSTML

Showing 0 of 3 quarters

Position history for RURubric Capital Management LP's holdings in STEMLINE THERAPEUTICS INC

As of its Q1 2020 13F, Rubric Capital Management held 3,347,141 shares of STML (Stemline Therapeutics), worth $16.2M. Rubric Capital Management listed STML in 2 quarterly 13F filings through Q1 2020. STML was 2.6% of Rubric Capital Management's reported 13F portfolio.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Optional analytics helps us improve. How it’s used